Bill Text: CA AB2680 | 2023-2024 | Regular Session | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Alzheimer’s disease.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Passed) 2024-09-21 - Chaptered by Secretary of State - Chapter 335, Statutes of 2024. [AB2680 Detail]

Download: California-2023-AB2680-Introduced.html


CALIFORNIA LEGISLATURE— 2023–2024 REGULAR SESSION

Assembly Bill
No. 2680


Introduced by Assembly Member Aguiar-Curry

February 14, 2024


An act to amend Section 1568.17 of the Health and Safety Code, relating to Alzheimer’s disease.


LEGISLATIVE COUNSEL'S DIGEST


AB 2680, as introduced, Aguiar-Curry. Alzheimer’s disease.
Existing law requires the Secretary of California Health and Human Services to be responsible for oversight and coordination of programs serving people living with Alzheimer’s disease and related conditions, and their families. Existing law establishes the Alzheimer’s Disease and Related Disorders Advisory Committee in the California Health and Human Services agency, and specifies the committee’s duties, including requirements for making policy and plan recommendations.
This bill would rename the advisory committee to the Alzheimer’s Disease and Related Conditions Advisory Committee, and expand the number of members serving on the committee from 14 to at least 21, but not more than 25, members. The bill would prescribe the qualifications of certain members on the committee. The bill would, in the provisions governing the committee, revise references to Alzheimer’s disease to also refer to related conditions.
Vote: MAJORITY   Appropriation: NO   Fiscal Committee: YES   Local Program: NO  

The people of the State of California do enact as follows:


SECTION 1.

 Section 1568.17 of the Health and Safety Code is amended to read:

1568.17.
 (a) The California Health and Human Services Agency shall establish an Alzheimer’s Disease and Related Disorders Conditions Advisory Committee consisting of 14 members selected as follows: representing the diversity of California and that consists of at least 21, but not more than 25, members, which shall include, but not be limited to, all of the following:
(1) One representing the field of academic medical research.
(2) One representing the field of social research.
(3) One representing the field of mental health.
(4) One representing the Alzheimer’s day care disease or related conditions daycare resource centers.
(5) One representing the Alzheimer’s disease or related conditions diagnostic and treatment centers.
(6) One representing local health jurisdictions.

(6)

(7) Two representing families of persons suffering from living with Alzheimer’s disease or related disorders. conditions.

(7)

(8) Two representing organizations providing services to persons living with Alzheimer’s disease patients. or related conditions.

(8)One

(9) Two representing a consumer organization representing persons with Alzheimer’s disease. disease or related conditions.

(9)

(10) One representing a member of the State Bar who is familiar with the legal issues confronting those living with Alzheimer’s disease victims or related conditions and their families.

(10)

(11) Two people who have been diagnosed with Alzheimer’s disease to serve one-year terms. or a related condition.
(12) One representing first responders.
(13) One commissioner from the California Commission on Aging who has expertise regarding Alzheimer’s disease or related conditions.
(14) One representing primary care physicians.

(11)

(15) The Secretary of California Health and Human Services or his or her their designee.
(16) Two ex officio, nonvoting members, consisting of one Senator appointed by the Senate Committee on Rules and one Member of the Assembly appointed by the Speaker of the Assembly. These members shall participate in the activities of the committee to the extent that their participation is not incompatible with their respective positions as Members of the Legislature.
(17) Up to four additional members selected by the Secretary of California Health and Human Services.
(b) Members described in paragraphs (1) to (14), inclusive, and paragraph (17), of subdivision (a) shall serve at the pleasure of the Secretary of California Health and Human Services. Members described in paragraph (16) of subdivision (a) shall serve at the pleasure of their appointing authority. The agency secretary may establish fixed terms for advisory committee membership. For purposes of continuity, those terms shall be staggered.
(c) Members shall serve without compensation, but shall receive reimbursement for travel and other necessary expenses actually incurred in the performance of their official duties.
(d) The Alzheimer’s Disease and Related Disorders Conditions Advisory Committee shall do all of the following:
(1) Provide ongoing advice and assistance to the administration and the Legislature as to the program needs and priorities of the target population.
(2) Provide planning support to the administration and the Legislature by updating recommendations of the 1987 California Alzheimer’s Disease Task Force Report and regularly reviewing and updating recommendations as needed.
(3) Appoint a chairperson and vice chairperson.
(4) Meet quarterly.
(e) The Alzheimer’s Disease and Related Disorders Conditions Advisory Committee shall do all of the following when making policy and plan recommendations:
(1) Consult with a broad range of stakeholders, including, but not limited to, people diagnosed with Alzheimer’s disease, family disease or related conditions, family members or informal caregivers, community-based and institutional providers, Alzheimer’s disease or related conditions researchers and academicians, formal caregivers, the Alzheimer’s Association, the California Commission on Aging, and other state entities.
(2) Consider the recommendations of other state plans, including, but not limited to, the Olmstead Plan, the Long-Range Strategic Plan on Aging, and the California Department of Aging’s State Plan on Aging.
(3) Consider cultural and linguistic factors that impact persons with Alzheimer’s disease or related conditions and their families who are from diverse populations.
(4) Review current state policies and practices concerning care and treatment related to Alzheimer’s disease and other dementia disorders, related conditions, and develop recommendations concerning all of the following issues:
(A) Community-based support for California’s diverse people with Alzheimer’s disease or related conditions and their family members. members or informal caregivers.
(B) Choices for care and residence for persons with Alzheimer’s disease or related conditions and their families.
(C) An integrated public health care management approach to Alzheimer’s disease or related conditions in health care settings that makes full use of dementia care practices.
(D) The dementia competence of health care professionals.
(E) Early identification and intervention through increasing public awareness of Alzheimer’s disease. disease and related conditions.
(f) All meetings of the advisory committee, and any subcommittees thereof, shall be open to the public and adequate notice shall be provided in accordance with Article 9 (commencing with Section 11120) of Chapter 1 of Part 1 of Division 3 of Title 2 of the Government Code.

feedback